Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion
ISRN Cardiology · 2011
DOI: 10.5402/2011/176834 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Cardiology, 2011. Verfasst von D E Thomas und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Cardiology, University Hospital of Wales, Heath Park, Cardiff CF14 4XN Wales, UK. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Despite the availability of potentially curative interventions for atrial fibrillation, there remains an important role for conventional anti-arrhythmic therapy and anti-coagulation combined with direct current cardioversion. Unfortunately, the latter approach is disturbed by high recurrence rates of atrial fibrillation. In recent years, several adjunctive therapies have emerged which may facilitate the maintenance of sinus rhythm. These novel therapies and their potential mechanisms of action are reviewed in this article.
Autor:innen und Institutionen
- The Department of Cardiology, University Hospital of Wales, Heath Park, Cardiff CF14 4XN Wales, UK.
Zitieren
APA
Thomas, D. E., Yousef, Z., & Anderson, R. A. (2011). Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion. ISRN Cardiology. https://doi.org/10.5402/2011/176834
Vancouver
Thomas DE, Yousef Z, Anderson RA. Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion. ISRN Cardiology. 2011. doi:10.5402/2011/176834
BibTeX
@article{Thomas2011,
author = {Thomas, D E and Yousef, Z and Anderson, R A},
title = {Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion},
journal = {ISRN Cardiology},
year = {2011},
doi = {10.5402/2011/176834}
}
EUVIMED